Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Reaches New 52-Week Low - Time to Sell?

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $174.54 and last traded at $174.54, with a volume of 30 shares changing hands. The stock had previously closed at $178.25.

Analyst Ratings Changes

Separately, Guggenheim upgraded Sartorius Aktiengesellschaft to a "strong-buy" rating in a research note on Thursday, December 19th.

Sartorius Aktiengesellschaft Price Performance

The company has a market capitalization of $5.66 billion, a P/E ratio of 125.37 and a beta of 1.11. The company has a debt-to-equity ratio of 1.17, a current ratio of 2.02 and a quick ratio of 1.13. The company has a fifty day moving average price of $204.32 and a 200 day moving average price of $200.48.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last issued its earnings results on Monday, February 17th. The company reported $1.11 earnings per share for the quarter. The firm had revenue of $967.37 million during the quarter. Sartorius Aktiengesellschaft had a net margin of 2.48% and a return on equity of 7.33%.

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.